🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We have a couple of Postdoc openings in our proteomics lab, to study protein synthesis and degradation kinetics using pulse-SILAC approaches. Please get in touch if you are interested! elxw.fa.em3.oraclecloud.com/hcmUI/Candidat…

So excited to see our work featured on the cover of The EMBO Journal! The image is the combination of a key experiment from our paper and clever micropatterning of PUFFFIN cells.

Excited to share our new paper led by PhD student Diego Chillón Pino with Mihaly Badonyi and Colin Semple

Are you interested in AI and structural biology, genetics and the non-coding (aka “dark”) genome? A PhD studentship through the UKRI AI and biomedical innovation programme at The University of Edinburgh Institute of Genetics and Cancer has become available with myself and prof Joe Marsh

Join us April 3-4th 2025 for an exciting conference in Edinburgh - exploring difficult to access aspects of genetics, cellular and structural biology! Low registration cost for students and postdocs, thanks to The Company of Biologists! lnkd.in/eq2srkGv

Happy to see our predictive scores integrated into DECIPHER! We hope they will help clinicians uncover the molecular mechanisms driving dominant disease. Huge thanks to the team at The DECIPHER Project for their support. A follow-up study is underway to improve predictions—stay tuned

In our latest study with Joe Marsh, we extend our work on phenotype-level molecular mechanism prediction. Read more here: biorxiv.org/content/10.110…

Structure-informed classification of RyR1 variants highlights limitations of current predictors and enables clinical interpretation medrxiv.org/cgi/content/sh… #medRxiv

New paper out in Genome Biology! 🎉 We lay out best-practice guidelines for releasing variant effect predictors, developed through the Atlas of Variant Effects Alliance Atlas of Variant Effects Alliance Open, interpretable, and clinically useful VEPs are the goal. 📄 doi.org/10.1186/s13059…